The Effectiveness of Conservative Treatment in Patients With Complex Regional Pain Syndrome.
The Effectiveness of Individualized Physical Therapy and Functional Neurology Treatment Protocol in Conjunction With Optimizing Medication and Repetitive Transcranical Magnetic Stimulation in Patients With Complex Regional Pain Syndrome.
1 other identifier
interventional
156
1 country
1
Brief Summary
The aim of the study is to investigate and improve non-pharmacological rehabilitation methods for patients with Complex Regional Pain Syndrome (CRPS) to reduce pain and restore work and functional capacity to lower overall treatment costs. Current treatment methods offer limited rehabilitation potential for this challenging pain condition, so efforts should be made to raise the level of care and rehabilitation for a disease that often causes long-term and severe reductions in patients' functional and occupational abilities. CRPS patients almost always have to substantially reduce their work hours or withdrawn from the workforce for extended periods, and often permanently, increasing the urgency of strengthening rehabilitation approaches; a CRPS symptoms can end a patient's productivity for society. In addition, commonly used medications are a significant expense for both individuals and the healthcare system. CRPS rarely resolves fully, and even with extensive rehabilitation only a small proportion of patients regain sufficient improvement to return to work at a level of at least 60% capacity. Participants will be recruited from the Department of Physical Medicine and Rehabilitation at Oulu University Hospital, where CRPS diagnostics for the Northern Ostrobothnia area are primarily conducted. The study will be carried out at OYS rehabilitation outpatient clinics. A total of 39 participants will be recruited into each of four study groups, for an overall sample size of 156 individuals. Each study group will receive repetitive transcranial magnetic stimulation (rTMS) at some point, and functional neurological rehabilitation will be combined with rTMS in varying ways (content and timing will differ between groups). All participants will receive basic CRPS rehabilitation (physiotherapy and occupational therapy) that is provided for all RPS patients, and the timing of this relative to rTMS will also be varied. Recruitment is planned to begin in a autumn 2025.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2033
October 6, 2025
September 1, 2025
5.3 years
September 28, 2025
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient specific functional scale (PSFS)
Patient names three important tasks that are compromised by the CRPS and label them by number (from 0 to 10) according the to the ability to perform them at the day of evaluation. Higher the number, better the function (from 0 to 30)
Enrollment, 6, 12 and 36 months.
Visual analog scale (VAS)
Participant is asked to mark with a vertical line the pain experienced during the day of evaluation into the 10cm horizontal line.
Enrollment, 6, 12 and 36 months
Secondary Outcomes (6)
Jenkis sleep questionnaire
Enrollment, 6, 12 and 36 months. During the rTMS treatment
Amount of sleep
Enrollment, 6, 12 and 36 months. During the rTMS treatment
Beck Depression Inventory
Enrollment, 6, 12 and 36 months
DEPS
Enrollment, 6, 12 and 36 months
Pain Self-Efficacy Questionnaire (PSEQ)
Enrollment, 6, 12 and 36 months
- +1 more secondary outcomes
Other Outcomes (4)
General well-being question
ENrollment, 6, 12 and 36 months
Tampa Scale of Kinesiophobia
Enrollment, 6, 12 and 36 months
Right-left discrimination
Enrollment, 6, 12 months
- +1 more other outcomes
Study Arms (4)
Control group
ACTIVE COMPARATOROptimizing medication (6mo) followed by rTMS and basic physical therapy rehabilitation (6mo)
Early functional neurological rehabilitation
EXPERIMENTALEarly functional neurological rehabilitation with optimizing medication (6mo) followed by rTMS and basic physical therapy rehabilitation (6mo)
Early maximal rehabilitation
EXPERIMENTALEarly functional neurological and physical therapy rehabilitation with optimizing medication (6mo) followed by rTMS (6mo)
Basic treatment protocol
OTHEREarly physical therapy rehabilitation with optimizing medication (6mo) followed by rTMS (6mo)
Interventions
2 weeks starting period (10 treatment days) followed by 5 treatment once a month.
10 sessions with physical (or occupational) therapist with special education for treating CRPS
4 to 6 sessions with specialized OMT-physical therapist who will aim to improve the neurological deficits of the CRPS patient
Aim is to optimize the medication of the CRPS patient according the the medication guidelines
Eligibility Criteria
You may qualify if:
- CRPS symptoms maximum of 5 year at the time of diagnosis (CRPS 1 and 2)
- to 70-year-old
- rTMS treatment is granted by university hospital pain clinic (by multidisciplinary group)
- Voluntary to participate into the study
You may not qualify if:
- CRPS symptoms started over five years ago (although diagnosed first time now)
- No other outpatient/inpatient rehabilitation during the study rehabilitation period (insurance company or other third party)
- Under 18-years-old of over 70-years-old
- No eligible to rTMS treatment or for other reason rTMS treatment was not granted by university hospital pain clinic (by multidisciplinary group)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oulu University Hospitallead
- The Maud Kuistila Memorial Foundationcollaborator
Study Sites (1)
Oulu University Hospital, Pain Clinic
Oulu, North Ostrobothnia, 90100, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jani M Takatalo, PhD, MD, PRM Specialist
Oulu University Hospital, Pain Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Some care providers (rTMS)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief Physician, Pain Clinic
Study Record Dates
First Submitted
September 28, 2025
First Posted
October 6, 2025
Study Start
September 30, 2025
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2033
Last Updated
October 6, 2025
Record last verified: 2025-09